Krox-20, originally identified as a member of bimmediate-earlyQ genes, plays a crucial role in the formation of two specific segments in the hindbrain during early development of the vertebrate nervous system. Here we cloned a genomic sequence of Xenopus and studied functions of a promoter element in the flanking sequence and associated transcription factors, which function in early Xenopus embryos. Using the luciferase reporter assay system, we showed that the 5Vflanking sequence was sufficient to induce luciferase activities when the reporter construct was injected into embryos at the eight-cell stage. Deletion and mutagenesis analyses of the 5Vflanking sequence revealed a minimal promoter element that included two known subelements, a CArG-box and cAMP response element (CRE) within a stretch of 22 bp nucleotide sequence (À72 to À51 from the transcription initiation site), both of which were essential for the promoter activity. The gel mobility shift assay indicated that these two subelements bound to some components in whole cell extracts prepared from stage 20 Xenopus embryos. Antibody supershift and competition experiments revealed that these components in cell extracts were serum response factor (SRF) and a member of CRE binding protein (CREB) family proteins that bound the CArG-box and CRE, respectively. They appeared to assemble on the minimal promoter element to produce a novel ternary complex. When we injected mRNA of a dominant-negative version of Xenopus SRF (XSRFDC) into animal pole blastomeres at the eight-cell stage, expression of XKrox-20 in the nervous system as well as the minimal promoter activity was strongly suppressed. Suppression by XSRFDC was counteracted by coexpressed wild-type XSRF. These results indicate that XSRF functions as an endogenous activator of XKrox-20 by forming a ternary complex with CREB on the minimal promoter element. D
Introduction
The Krox-20 gene encodes a transcription factor that contains three consecutive C 2 H 2 zinc finger domains (Chavrier et al., 1988; Vesque and Charnay, 1992) . During early development of the vertebrate nervous system, Krox-20 is expressed in the neuroectoderm and plays a crucial role in development of rhombomeres 3 (r3) and 5 (r5) in the hindbrain, the neural crest (Bradley et al., 1993; Wilkinson et al., 1989) , and Schwann cells (Topilko et al., 1994) . In rhombomeres, the sites of Krox-20 expression overlap with those of a variety of transcription factor genes such as Hox genes (Nonchev et al., 1996a,b) , EphA4 (Sek-1) (Irving et al., 1996) , and Kreisler/mafB (Frohman et al., 1993; Marin and Charnay, 2000a,b; McKay et al., 1994) . Since Krox-20 protein has been shown to directly bind to cis-elements in some Hox genes (Chavrier et al., 1990; Nonchev et al., 1996a,b; Vesque et al., 1996) and EphA4 (Sek-1) (Theil et al., 1998; Vesque et al., 1996) , Krox-20 appears to contribute to the formation of r3 and r5 by regulating expression of these transcription factors . Indeed, analysis of phenotypes of knockout mice has revealed that deletion of Krox-20 results in a total loss of r3 and r5, although overall segmentation in other parts of the hindbrain is maintained (Schneider-Maunoury et al., 1993 .
Krox-20 was originally identified as a member of bimmediate-earlyQ genes that include proto-oncogenes, such as c-fos and c-Jun (reviewed in Herschman, 1991) . Indeed, in NIH3T3 cells, the expression of mouse Krox-20 was induced within 15 min following serum stimulation in the absence of de novo protein synthesis (Chavrier et al., 1988) . By deletion analysis and mutagenesis, serum responsiveness of the promoter region of human Krox-20 homologue egr-2 was traced to a CArG-box (sequence of the form CC (A/T) 6 GG) in the transient transfection assay performed in NIH3T3 cells (Rangnekar et al., 1990) . A similar CArGbox was identified as a regulatory element in the promoter region of a variety of genes including c-fos and egr-1 (Herschman, 1991) . These promoters have been shown to be activated by binding of a serum response factor (SRF) to the CArG-box (reviewed in Panitz et al., 1998; Shore and Sharrocks, 1995) . It was suggested that the CArG-box in the egr-2 promoter region also bound SRF (Rangnekar et al., 1990) . However, it is still not known whether the CArG-box and SRF are also involved in the expression of Krox-20 in the neuroectoderm during early development of the vertebrate nervous system.
In Xenopus embryos, Krox-20 is also expressed in the neuroectoderm at specific sites along the anteroposterior (A/P) axis: its expression starts at the late gastrula stage, and the sites of expression are confined to r3, r5, and adjacent neural crest regions at later stages (Bradley et al., 1993; Nieto et al., 1992) . Here we cloned a genomic sequence of Xenopus and identified a minimal promoter element that was active in early Xenopus embryos. The minimal promoter element included two known transcription-factor-binding sites, a CArG-box and a core sequence of cAMP response element (CRE), within a stretch of 22 bp nucleotide sequence. CRE has been shown to mediate the transcriptional response to an elevated level of cAMP by binding to a member of CRE binding protein (CREB) family (Gonzalez et al., 1989; Ziff, 1990) . Both SRF and CREB proteins are expressed in Xenopus embryos at gastrula and neurula stages (Lutz et al., 1999; Mohun et al., 1991) . In this study, we showed that SRF and a member of CREB family proteins assembled on the minimal promoter element to produce a novel ternary complex. In addition, a dominant-negative version of Xenopus SRF (XSRFDC) suppressed expression of endogenous XKrox-20 in the nervous system. We conclude that the identified minimal promoter element plays a role in transcriptional activation of Krox-20 during early Xenopus development by forming a novel ternary complex with SRF and CREB proteins.
Materials and methods

Animal care
Methods for keeping frogs and obtaining embryos have been described previously (Mitani and Okamoto, 1989) .
Cloning of XKrox-20 genomic DNA from Xenopus library Probe for XKrox-20 in screening a genomic library (STRATAGENE) was prepared using PCR that was performed on cDNA synthesized from Xenopus neurula stage mRNA. A pair of primers was designed within 0.8 kbp 5Vregion of previously reported XKrox-20 cDNA (Bradley et al., 1993) , which was devoid of the zinc finger domains: U, 5V-CACAGCTGCCAAGGACATCTAAGG-3Vand D, 5V-AAGAGCGCCGAGTAGTCGGG-3V. The cloned cDNA probe was used for screening of about 10 7 recombinant phage.
5VRACE
Using 5V-Full RACE Core Set (TaKaRa), 5VRACE was performed according to the manufactureVs recommendations. RT primer was designed about 200 bp downstream of translation initiation site and its 5Vend was phosphorylated: RT, 5V-CAGAGATCGCTTGTC-3V. Two pairs of primers were designed for nested PCR: U1, 5V-GCAGTTTATCTA-TAGCTTTGGCGGCCATGG-3V and D1, 5V-CAGT-GACTTTCAGTAGTTTTCTGCAGCAGATCC-3V and U2, 5V-GCAAGTGCCCCCCAATATCAACTCAACC-3V and D2, 5V-GCGTCTGTCACCATCTTCCCTAATGTGG-3V.
Construction of expression plasmids
A genomic sequence cloned in a recombinant phage, which contained the longest 5V flanking sequence, was cut out by NotI and subcloned into the pBluescript II SK (À) for further analyses. To prepare reporter constructs containing 5V flanking sequence of various length, the NcoI fragment (À1010 to +218) was cloned into a luciferase reporter vector pGL3-Basic (Promega) using NcoI site in the vector (À1010/Luc). Constructs, À3987/Luc and À3210/Luc, were then generated by serial addition of appropriate restriction fragments to À1010/Luc. À232/Luc was generated by removing SmaI fragment (one end at À232 and the other upstream end in the vector) from À1010/Luc. Sequences of the intron and 3Vflanking regions were amplified by PCR. These PCR products were subcloned into the pGEM-T (Promega) and then checked by sequencing (ABI). Correct clones were recloned into BamHI site in the reporter vector pGL3. A pair of primers for the intron was designed: U, 5V-GGATCCGTAAGGGCTGTGTTTGTTTATGG-3V and D, 5V-GGATCCCTGCGGGGGAAAGGACATTGG-3V. A pair of primers for the 3V flanking region was designed: U, 5V-GGATCCCACTTGCACAGGGACAGGGTACC-3V and D, 5V-GGATCCCGCTCGCTGCTTGTGTAGGACC-3V. Fragments for the 5V deletion constructs with shorter length of 5Vflanking sequence were generated by PCR using the same downstream primer and various upstream primers representing a series of deletions in the XKrox-20 promoter region. The downstream primer was designed immediately upstream of the translation initiation site. À77/Luc to À73/Luc, À71/Luc, À70/Luc, and À56/Luc constructs were prepared by inserting each of the fragments into XhoI and NcoI sites in pGL3. Otherwise, the À72/Luc construct was prepared by inserting into BglII and NcoI sites in pGL3. A downstream primer was 5V-CTTCCATGGTCTCAG-CAAGTGC-3V. Upstream primers were: À77/Luc U, 5V-
Fragments for 3V deletion constructs were double-stranded synthetic oligonucleotides that had the KpnI site at the 5V end and either XhoI site (for (À72 to À1)/Luc, (À72 to À30)/Luc, (À72 to À40)/Luc, and (À72 to À51)/Luc) or BglII site (for (À72 to À50)/Luc and (À72 to À52 through À55)/Luc) at the 3Vend. Sequences used can be seen in Fig.  1B . These fragments were cloned into either KpnI-XhoI sites or KpnI-BglII sites in the modified pGL3. This modified vector was constructed by inserting 74 bp sequence from a Xenopus heat shock protein gene (Bienz, 1984) containing TATA-box into BglII-NcoI sites in pGL3. The sequence used was 5V-AGATCTCAGAGTTCTGTA-TAAATACAGCGGGTTTGAAGCGATGTGGAAGTAG-CAGAATCTAAGCTGACACTTGTGCCATGG-3V.
Microinjection of reporter constructs
pRL-CMV that was used as an internal control and pGL3 constructs were injected into animal-dorsal or vegetalventral blastomeres of both sides at the eight-cell stage in 0.5Â MBS plus 3% Ficoll. Quantities of injected constructs with various degree of deletion were adjusted to the same amount on the molar base, and constructs were injected at 3 Â 10 À18 mol/1.26 nl into a blastomere of eight-cell stage embryos. A group of embryos injected was maintained at 14.58C for 2 h in 0.5Â MBS plus 3% Ficoll and then transferred to 0.05Â MBS plus 3% Ficoll. The temperature of incubation was gradually increased to 238C and injected embryos were cultured up to stage 20.
Luciferase assay
The luciferase assay was performed using Dual-Luciferase Reporter Assay System (Promega). In these experiments, firefly luciferase (pGL3) was used to assay the promoter activity, whereas Renilla luciferase (pRL-CMV) was used for normalization. When a group of embryos grew up to stage 20, they were washed with 0.05Â MBS, transferred to 0.5 ml Treff tube, and were frozen by liquid nitrogen. The tube was set on ice to thaw and 30 Al Passive Lysis buffer (Promega) per embryo was added to homogenize the tissues by a pestle. The lysate was centrifuged at 15,000 rpm, 48C for 3 min. A 10-Al clear supernatant was used to assay with 100-Al firefly or 100-Al Runilla luciferase substrate (Promega), respectively. Experiments were repeated several times. One representative experiment was shown for each figure. Because absolute levels of reporter gene activity were influenced by the batch of eggs, each experiment was carried out on eggs laid by a single female.
Gel mobility shift assays
Whole cell extracts were prepared from Xenopus stage 20 embryos and gel mobility shift assays were performed as described (Huang et al., 1995; Haremaki et al., 2003) . DNA fragments used as probes were 3V end-labeled with digoxygenin-11-ddUTP according to the manufacture's recommendations (Roche Diagnostics; DIG Gel Shift Kit). Supershifts were generated by adding 1 Al of affinity-purified polyclonal antibody directed against a peptide mapping within the C terminal domain of human SRF (Santa Cruz Biotechnology) and monoclonal antibody directed against Ser 133 phosphorylated peptide in CREB (Cell Signaling Technology), separately or in combination. DNA-protein complexes were separated by electrophoresis through 3.5% polyacrylamide gel containing 0.5Â TBE and 2.5% glycerol.
Gels were further processed according to the manufacture's recommendation (Roche Diagnostics; DIG Gel Shift Kit). Sequences of double-stranded synthetic oligonucleotides used as probe or competitor were as follows: 5VGTCCTTA-TATGGGCAGTGACGTCACGCACAT 3V (wild type); 5V GTCgagATATGGGCAGTGACGTCACGCACAT 3V (CArG-box mutated); 5V GTCCTTATATGGGCAGTGcatg-CACGCACAT 3V(CRE-mutated).
Microinjection of mRNA, in situ hybridization, microculture of ectoderm cells, and quantitative RT-PCR assay These were done essentially as described previously (Hongo et al., 1999) . GFP mRNA was injected for lineage tracing or mRNA injection control. Double in situ hybridization experiments were performed following the methods described by Sive et al. (2000) . The entire and deleted coding sequences of Xenopus serum response factor (XSRF) were amplified by PCR and subcloned into pSP64T (Belaguli et al., 1997; Mohun et al., 1991) . Capped synthetic mRNA for microinjection was made in vitro by mMessage mMachine (Ambion).
Results
Isolation and structural characterization of the Xenopus Krox-20 gene
A cDNA probe for screening a Xenopus genomic library was prepared by PCR using primers designed within the 0.8 kbp 5Vregion of previously reported XKrox-20 cDNA (Bradley et al., 1993) , which was devoid of zinc finger domains. The cloned cDNA was slightly different from the previously reported XKrox-20 cDNA in the nucleotide sequence. The two cDNA clones may represent divergent copies of different XKrox-20 genes present in the pseudo-tetraploid genome of Xenopus laevis (Graf and Kobel, 1991) . Using newly isolated cDNA as a probe, we screened a genomic library constructed from Xenopus skeletal muscle DNA and obtained several colinear genomic clones. Among those clones, the one that contained the longest 5V flanking sequence was used for further analyses. Comparison of the XKrox-20 genomic sequence with cDNA sequences showed that the XKrox-20 gene has a single intron, 1.4 kbp in length, within the coding sequence (Fig. 1A) . The genomic clone that we isolated also contained the 5V flanking sequence, about 4 kbp in length and the 3Vflanking sequence, about 7 kbp in length. The overall structure of XKrox-20 gene was similar to that of human Krox-20 gene egr-2 (Rangnekar et al., 1990) , which contains two exons and one intron in the conserved position (Fig. 1A) .
The transcription initiation site of XKrox-20 was mapped by primer extension analysis using the 5V RACE method. The determined sequence around the initiation site was aligned with those of human (Rangnekar et al., 1990 ) and mouse Cortner and Farnham, 1990) Krox-20s (Fig. 1B) . In addition to the TATA-box, a stretch of 43 bp sequence (corresponding to the sequence from À90 to À48 in Xenopus) was highly conserved among the three sequences, which included three previously known binding motifs for the respective transcription factors; the Etsbinding site (EBS), the CArG-box, and the cyclic AMP response element (CRE).
Identification of a minimal promoter element within the 5V flanking region of XKrox-20
We first asked whether our genomic clone contains sequence elements that activate expression of XKrox-20 in early embryonic development. For this purpose we subcloned the 5V flanking region, intron, and 3V flanking region into a firefly luciferase reporter plasmid pGL3, separately or in combination (Figs. 2A and C). These constructs were injected into two animal-dorsal (AD) or two vegetal-ventral (VV) blastomeres at the eight-cell stage together with an internal standard plasmid pRL-CMV (Fig. 2B) . We found that robust luciferase activities were induced only when the reporter constructs contained the 5V flanking region (Fig.  2C) . The intron or 3Vflanking region alone was not effective in inducing luciferase activities. We also found that induction of luciferase reporter activities occurred irrespective of the site of injection, AD, or VV blastomeres, indicating that elements present in the 5V flanking region represent basal promoters that function throughout the embryo. The correct spatial expression of XKrox-20 may require additional repressor elements outside the cloned genomic sequence.
To identify promoter elements in the 5Vflanking region, deletion analysis was carried out. For this purpose we first generated a series of 5V deletion constructs by subcloning appropriate restriction fragments into pGL3. These constructs were injected into two AD blastomeres at the eight- cell stage. Deletion down to À232 (relative to the transcription initiation site) did not significantly affect luciferase activities, but deletion down to À56 eliminated the activity (Fig. 3A) . This result indicated that the 5V boundary of a promoter element in the 5V flanking sequence is present between À232 and À56. To precisely locate the 5Vboundary of the promoter element, a series of 1 base-pair deletion constructs from À77 to À70 was constructed by PCR, and their luciferase activities were assayed (Fig. 3B) . When the sequence was deleted further than À71, the promoter activity was heavily reduced. Although the extent of reduction varied somewhat in several series of experiments, it was always substantial as compared to the basal promoter activity of the control pGL3 vector. Thus we conclude that the 5Vboundary of a minimal promoter element is À72 from the transcription initiation site. This position of À72 corresponds to 1 bp upstream of the CArG-box (Fig. 1B) .
To similarly locate the 3V boundary of the minimal promoter element, a series of deletion constructs from À1 to À55 was generated by PCR, and their luciferase activities were assayed (Fig. 3C) . These constructs had the common 5Vboundary at À72 and a heterologous TATA-box-contain- Fig. 3 . Identification of a minimal promoter element within the 5Vflanking sequence of XKrox-20. A series of deletion constructs was injected into two AD blastomeres at the eight-cell stage and relative luciferase activities are presented as described for Fig. 2C. (A and B) A series of 5Vdeletion constructs from À3987 to À56 that were indicated on the left of each histogram was assayed. (C) A series of 3Vdeletion constructs from À1 to À55, which had a fixed 5V boundary at À72, was assayed. These constructs had a heterologous TATA-box-containing sequence in the immediate upstream of the luciferase-coding sequence. Injected reporter constructs are shown schematically on the left of histogram.
ing sequence in the immediate upstream of the luciferasecoding sequence. The heterologous sequence was derived from the gene of Xenopus heat shock protein (Bienz, 1984) and required to replace the intrinsic TATA-box-containing sequence that was deleted in most constructs examined (see Fig. 1B ). A series of 3V deletion constructs up to À51 exhibited high luciferase activities, but further deletion over À52 significantly reduced the activities (Fig. 3C ) in several series of experiments. Taken together, these results indicate that the minimal promoter element required for expression of XKrox-20 in early Xenopus embryos is the sequence between À72 and À51 from the transcriptional start site.
There were two known binding sites for transcription factors packed in the identified minimal promoter element of XKrox-20 (Fig. 1B) . One is a CArG-box (CC (AT) 6 GG, À71 to À62), which serves as the binding site for serum response factor (SRF). The other is the core sequence of cAMP response element (CRE; GACGTC, À56 to À51), which serves as the binding site for cAMP response element binding protein (CREB) and other structurally related proteins (CREB family proteins). The sequences of the two binding sites are well conserved among Krox-20 genes of three different species (Fig. 1B) . To verify the requirement of the two binding sites for the activity of minimal promoter element in early Xenopus embryos, we examined whether mutations in the binding sites impair the promoter activity. For this purpose, the CArG-box sequence CCTTA-TATGG and the CRE core sequence GACGTC were mutated to CgagATATGG and GcatgC, respectively. Mutation of either the CArG-box or CRE sequence significantly reduced the luciferase activity, and mutation of both sequences virtually eliminated it (Fig. 4) . These results were reproducibly obtained, indicating that both the CArGbox and CRE sequences were required for the function of the minimum promoter element in early Xenopus embryos.
A novel ternary complex formed on the minimal promoter element by SRF and CREB To obtain further insight into the activation mechanism of minimal promoter element in Xenopus embryos, we examined whether this element interacts with proteins present in whole cell extracts from stage 20 Xenopus embryos using the gel mobility shift assay (Fig. 5) . The end- Fig. 4 . Analysis of the effects of mutation of CArG-box and CRE on the minimal promoter activity. The original construct had the minimal promoter element (À72 to À51) and the heterologous TATA-box-containing sequence as described for Fig. 3C . The CArG-box and CRE were mutated as indicated on the left of histogram (Â). Mutated promoter fragments were double-stranded synthetic oligonucleotides. The original and mutated constructs were injected into two AD blastomeres at the eight-cell stage and assayed. Relative luciferase activities are presented as percentages of the maximum value. Fig. 5 . A ternary complex formation on the minimal promoter element by SRF and CREB proteins. Binding reactions were carried out with end-labeled probe, either wild type or mutated, in the absence or presence of whole cell extracts from stage 20 embryos. Further additives are indicated below. Reaction mixtures were electrophoresed on 3.5% native polyacrylamide gel. In A and B, end-labeled wild-type probes (À73 to À43) were used. (A) Lane 1, probe alone; 2, probe plus extracts and no competition; 3, competition with unlabeled probe at 125-fold excess; 4, components in lane 2 plus anti-SRF; 5, components in lane 2 plus anti-pCREB; 6, components in lane 2 plus anti-SRF and anti-pCREB. (B) Lane 1: probe plus extracts and no competition; 2, competition with unlabeled CArGbox-mutated fragment at 125-fold excess; 3, competition with unlabeled CRE-mutated fragment at 125-fold excess. (C) Lane 1: end-labeled wild-type probe plus extracts; 2, end-labeled CRE-mutated probe plus extracts; 3, end-labeled CArG-box-mutated probe plus extracts; 4, components in lane 2 plus anti-SRF; 5, components in lane 3 plus anti-pCREB; 6, components in lane 1 plus anti-pCREB and anti-SRF. labeled 31 bp fragment (À73 to À43) containing the minimal promoter sequence migrated as a discrete band in the absence of whole cell extracts (Fig. 5A, lane 1) , but in the presence of extracts three shifted bands became evident (Fig. 5A, lane 2) . They are referred to as bands 1, 2, and 3 hereafter (see labels in Fig. 5A ). All the three bands disappeared by addition of a 125-fold molar excess of the unlabeled fragment (Fig. 5A, lane 3) , confirming the specificity of interaction of the labeled probe with whole cell extracts that yielded the three bands. To identify protein components in the extract that shifted the probe, the antibody supershift experiment was performed. An affinity-purified polyclonal antibody against the C terminal domain of human SRF (anti-SRF) supershifted bands 1 and 2, but not band 3 (Fig. 5A, lane 4) . This result suggested that SRF was present in whole cell extracts from stage 20 embryos, giving rise to bands 1 and 2. In contrast, a monoclonal antibody recognizing phosphorylated CREB and other CREB-family proteins (anti-pCREB) supershifted bands 1 and 3, but not band 2 (Fig. 5A , lane 5), suggesting that a member of CREB family proteins in the extracts gave rise to bands 1 and 3. When both anti-SRF and anti-pCREB were added, the supershifted band 1 was further shifted (Fig.  5A , lane 6, *). Addition of control IgG protein caused no change in the pattern of three bands (data not shown). Taken together, it is highly likely that band 2 was derived from binding of SRF to the CArG-box, while band 3 was derived from binding of a member of CREB-family proteins to CRE. SRF and CREB proteins appeared to assemble on the minimal promoter element to yield band 1 that was doubly supershifted by concomitant presentation of anti-SRF and anti-pCREB antibodies.
To confirm the binding specificities, the effect of unlabeled mutated fragments on the band pattern was examined. Mutations were introduced into the 31 bp wildtype fragment (À73 to À43) in a similar manner as described in the previous section. An unlabeled CArGbox-mutated fragment would compete with the labeled wildtype fragment only for CREB proteins, whereas an unlabeled CRE-mutated fragment would compete only for SRF. When the unlabeled CArG-box-mutated fragment was added in a 125-fold molar excess, bands 1 and 3 disappeared, as expected (Fig. 5B, lane 2) . In contrast, an addition of the unlabeled CRE-mutated fragment caused disappearance of bands 1 and 2, again as expected (Fig. 5B,  lane 3) . Finally, we directly examined band patterns derived from labeled mutated fragments. When the end-labeled CRE-mutated fragment was used as a probe, a single band emerged (Fig. 5C, lane 2) at the position of band 2 seen with the wild-type probe (Fig. 5C, lane 1) . In contrast, the endlabeled CArG-box-mutated fragment gave rise to a single band (Fig. 5C, lane 3) at the position of band 3 seen with the wild-type probe (Fig. 5C, lane 1) . Bands in lanes 2 and 3 were supershifted by addition of anti-SRF and anti-pCREB, respectively (Fig. 5C, lanes 4 and 5) , confirming the origin of bands 2 and 3. Comparison of the supershifted bands in lanes 4 and 5 with those obtained by the wild-type probe supported strongly the idea that the doubly supershifted band seen with the wild-type probe (Fig. 5A, lane 6 and Fig.  5C , lane 6, *) was derived from a ternary complex formed by SRF and CREB proteins that were assembled on the minimal promoter element.
Suppression of endogeneous XKrox-20 expression by inhibition of SRF in Xenopus embryos
We next examined the possible involvement of the ternary complex in the expression of endogenous XKrox-20. For this, a dominant-negative construct of Xenopus SRF (XSRFDC) was employed, which lacked the C-terminal half of Xenopus wild-type SRF (Belaguli et al., 1997) . The Cterminal region of SRF includes a transactivation domain and possibly a CREB-binding domain as well (Fig. 6A) . The dominant-negative SRF mutant thus mainly comprises the DNA-binding domain, thereby competing with endogenous SRF for the CArG-box. It may also fail to form a ternary complex with CREB (Hassler and Richmond, 2001 ). We first assessed the repressor capability of the mutant SRF by coinjecting XSRFDC mRNA into AD blastomeres at the eight-cell stage with a reporter construct containing the minimal promoter element. Overexpression of XSRFDC caused a profound suppression of the reporter activity, whereas wild-type XSRF had little, if any, effect on it (Fig.  6B ). Suppression by XSRFDC was counteracted by coexpression of wild-type XSRF, indicating that XSRFDC Fig. 6 . Suppression of the minimal promoter activity in the reporter construct by inhibition of SRF. (A) Structural features of wild-type XSRF and its dominant-negative version employed (XSRFDC). Black and gray boxes represent the C-terminal transactivation and the N-terminal DNA binding domains, respectively. (B) Suppression of the minimal promoter activity by XSRFDC and its rescue by wild-type XSRF. Synthetic mRNAs encoding XSRFDC or XSRF were coinjected with the minimal reporter construct described in Fig. 4 and pRL-CMV into two animal blastomeres of eight-cell stage embryos. The injected amounts of XSRFDC and XSRF mRNAs were 1.5 and 4.5 pg/blastomere, respectively. The total amount of injected mRNA was adjusted to 6.0 pg/blastomere by adding control GFP mRNA. Reporter activities were analyzed and presented as in Fig. 2B . specifically blocked endogenous XSRF on the minimal promoter element.
We then asked whether overexpression of XSRFDC affects the expression of endogenous XKrox-20 in the nervous system of Xenopus embryos. XSRFDC and lineagetracing GFP mRNAs were coinjected into two animal blastomeres on one side of eight-cell stage embryos, which would give rise to the middle to anterior part of the neuroectoderm of the injected side. Using GFP fluorescence as marker, we selected stage 20 embryos in which GFP expression in the injected side was clearly detected in the middle to anterior part of the nervous system, extending up to the cement gland (Figs. 7A and B) . These embryos were processed for in situ hybridization with digoxigenin-labeled RNA probe. In 67% embryos examined, expression of XKrox-20 in r3, r5, and adjacent neural crest regions was profoundly suppressed on the injected side (Table 1) , as exemplified in Fig. 7D . Twenty-eight percent of embryos was less affected, while the remaining 6% was unaffected. When GFP mRNA alone was injected instead of XSRFDC mRNA, no suppression was observed ( Fig. 7C and Table 1 ). The suppression by XSRFDC was counteracted by coexpression of wild-type XSRF, though complete rescue was hardly accomplished (Fig. 7E and Table 1 ). Some of the injected embryos were also examined for the expression of BF-1, a forebrain marker, as shown in Figs. 7C-E. In a series of experiments, 90% of embryos (28/31) exhibited suppression of XKrox-20 expression more or less, while only 6.5% of embryos (2/31) showed a distinct sign of suppression of BF-1 expression. The pattern of BF-1 expression in the remaining embryos (29/31) appeared to be marginally affected in that the expression domain was anteriorly dislocated and compressed slightly (Fig. 7D) . The extent of BF-1 expression in the domain was not significantly affected or rather slightly enhanced in some cases (Fig. 7D) . In another series of control experiments, we selected stage 20 embryos as above (Fig. 7A) and processed them for double in situ hybridization to detect BF-1 and lineage-tracing GFP mRNAs (Fig. 7F) . We confirmed that GFP mRNA was present in the BF-1-expressing region, as expected from GFP fluorescence data (Fig. 7A) . It was indicated that the expression of BF-1 was far less affected by XSRFDC than that of XKrox-20.
To further verify the action of XSRFDC, we examined the expression of another hindbrain marker XmafB that was expressed in r5, r6, and adjacent neural crest regions in Xenopus embryos (Ishibashi and Yasuda, 2001) , as in case of chick (Marin and Charnay, 2000a) . In chick, the normal expression of both mafB/kr and Krox-20 is regulated by FGF signaling (Marin and Charnay, 2000a) . We found that in 33% of injected embryos (12/36), the expression of XmafB was suppressed slightly or moderately (Fig. 7G) , but the extent of suppression was never profound as observed for XKrox-20 expression. In conclusion, XSRFDC did not generally alter gene expression in the middle to anterior neural region. XSRFDC and XSRF mRNAs were coinjected at 60 and 80 pg/blastomere, respectively. In C, D, and E, arrows point to the expression of XKrox-20, whereas arrowheads point to that of BF-1. (F) XSRFDC and lineage-tracing GFP mRNAs were coinjected as in D and double in situ hybridization was performed to visualize GFP mRNA (red signal), BF-1 transcript (green signal, indicated by arrowhead), and XKrox-20 transcript (green signal, indicated by arrow). (G) The same injection scheme as in F. Double in situ hybridization was performed to visualize GFP mRNA (red signal), BF-1 transcript (green signal, indicated by arrowhead), and XmafB transcript (green signal, indicated by arrow). (H) The same injection scheme as in F. Double in situ hybridization was performed to visualize GFP mRNA (red signal) and chordin transcript (green signal, indicated by arrow). (I) The same injection scheme as in F. Double in situ hybridization was performed to visualize GFP mRNA (red signal) and actin transcript (green signal, indicated by arrow).
It is possible that XSRFDC affects mesodermal development, thereby interfering XKrox-20 expression in the neuroectoderm, since SRF is shown to be involved in myogenesis (Belaguli et al., 1997) . However, in two-thirds of injected embryos, lineage-tracing GFP expression at gastrula stages was confined to the ectoderm region and not detected in the marginal zone, the future mesodermal tissue, as judged by GFP fluorescence. The remaining one-third of embryos exhibited GFP expression in the dorsalmost or dorsolateral narrow part of the marginal zone besides the ectoderm region in the injected side. When we examined the expression of chordin, a notochord marker, at stage 11.5-13, 15 out of 17 embryos showed no damage in the injected side as examined by double in situ hybridization (Fig. 7H) . In the remaining two embryos, moderate suppression was seen in the dorsalmost part where lineage-tracing GFP mRNA was present (data not shown). At stage 20, 11 out of 33 embryos exhibited slight suppression of the expression actin, a somite marker, in the injected side (Fig. 7I) . Taking into account that XSRFDC affected XKrox-20 expression in more than 90% of embryos injected and that the adjacent hindbrain marker XmafB was far less affected than XKrox-20, it was indicated that the loss of XKrox-20 expression in the hindbrain region was mainly due to a direct effect of XSRFDC on the neuroectoderm rather than through an indirect effect on mesodermal development.
We have previously shown that FGF induces Xenopus gastrula ectoderm cells in culture to express positionspecific neural marker genes along the anteroposterior axis in a dose-dependent manner; with higher doses eliciting more posterior marker genes (Kengaku and Okamoto, 1995) . Indeed, endogenous XKrox-20 was activated in a considerably higher FGF dose range than BF-1 when examined in the microculture assay; see Fig. 8A for the experimental design and compare GFP control series in Fig. 8B . It is useful to determine whether activation of endogenous XKrox-20 by FGF requires functional activities of XSRF. When XSRFDC was overexpressed in gastrula ectoderm cells in culture, FGF could hardly activate XKrox-20, while activation of BF-1 was unaffected (Fig. 8B) .
Taken together, these results indicate that XSRF functions as an endogenous activator of XKrox-20 by forming a ternary complex on the minimal promoter element with CREB.
Discussion
In this study, we cloned a genomic sequence of XKrox-20 and identified a minimal promoter element that functions in early Xenopus embryos within the 5V flanking sequence of the gene. The minimal promoter element contains a CArGbox and a core motif of CRE within a stretch of 22 bp sequence (À72 toÀ51), both of which are required for promoter activity. Gel mobility shift experiments indicate that SRF and CREB family proteins assemble on the minimal promoter element to form a novel ternary complex. Further, functional analysis using a dominant-negative version of XSRF (XSRFDC) indicates that the ternary complex plays a role in the activation of endogenous XKrox-20 during early Xenopus development.
A novel ternary complex on the minimal promoter element of XKrox-20
We have shown that SRF and CREB proteins were present in whole cell extracts from stage 20 Xenopus embryos (Fig. 5) . This observation is consistent with previous findings that these proteins are expressed in Xenopus embryos at gastrula and neural stages (Lutz et al., 1999; Mohun et al., 1991) . Blocking SRF function on the minimal promoter element by XSRFDC resulted in the suppression of XKrox-20 expression in the hindbrain and adjacent neural crest regions (Fig. 7D) . It is interesting to know whether blocking CREB function also causes the suppression of XKrox-20. It was reported, however, that overexpression of a dominant-negative version of CREB (CREB A133 ) did not change expression patterns of XKrox-20 in Xenopus embryos, though the data were not shown (Lutz et al., 1999) . CREB A133 mutated at serine 133 to alanine cannot be activated by phosphorylation, but still forms dimers with endogenous CREB family proteins. We could explain the negative result with CREB A133 by postulating that CREB A133 can still form the ternary complex with SRF to stabilize the binding of SRF to the CArG-box and that CREB itself is not directly involved in transactivation by the ternary complex.
The CArG-box has been shown to be present in the promoter region of other immediate-early genes such as cfos and egr-1 (Herschman, 1991) . In these promoters, the CArG-box and Ets-binding site (EBS) that immediately flanks the CArG-box form a composite element named serum response element (SRE). The SRF and Ets family transcription factors assemble on SRE to form a stable ternary complex (Panitz et al., 1998; Shore and Sharrocks, 1994; Wasylyk et al., 1998) . In the 5V upstream region of a As compared to expression on the uninjected side. b As exemplified in Fig. 7C . c As exemplified in Fig. 7E . d As exemplified in Fig. 7D . e Collected data from three independent series of experiments.
c-fos, CRE is present around À65 from the transcription initiation site in addition to SRE that is located around À300 (Renz et al., 1985) . Recent data suggest that the CREB binding protein (CBP), a transcriptional adapter, regulates transcriptional initiation by physically joining CREB on CRE with the ternary complex comprising SRF and Ets family proteins on SRE (Nissen et al., 2001; Ramirez et al., 1997) . It is interesting to explore whether CBP also binds to the unique ternary complex comprising SRF and CREB proteins that assemble on the minimal promoter element of XKrox-20. The binding may occur in combination with Ets family proteins on EBS that is present immediately upstream of the minimal promoter element and is well conserved among different species (Fig. 1B) . If so, the minimal promoter element that we have identified would provide a novel model system to investigate interactions among basic transcription factors such as SRF, CREB, Ets protein, and CBP.
Requirement of additional elements for proper regulation of XKrox-20 expression
The minimal promoter element of XKrox-20 induced luciferase activities in Xenopus embryos irrespective of the site of injection of the reporter construct, AD, or VV blastomeres (data not shown), as in the case of the whole 5V flanking sequence with or without the intron and 3Vflanking sequences (Fig. 2C) . AD blastomeres give rise to a large part of the embryonic neural tissue including r3 and r5 regions where XKrox-20 is specifically expressed, whereas VV blastomeres give rise to endodermal tissues such as digestive organs. Thus, our results indicate that there exist Control GFP or XSRFDC mRNA was injected at 60 pg/blastomere into four animal blastomeres of eight-cell stage embryos. When they reached stage 10, ectodermal tissues were isolated. The dissociated ectodermal cells were then inoculated into microculture wells at 200 cells/well. After completion of reaggregation by brief centrifugation, cells were cultured in the presence of increasing concentrations of bFGF until control embryos reached stage 23. The transcriptional levels of XKrox-20 and BF-1 were analyzed by RT-PCR (Kengaku and Okamoto, 1995; Hongo et al., 1999) . (B) Suppression of FGF-induced XKrox-20 expression in ectoderm cells by XSRFDC. Autoradiographs are shown of RT-PCR products of the transcripts from XKrox-20 and BF-1, both of which were coamplified with EF1a transcript, an internal standard (upper panels). Each RT-PCR product was quantified by a laser image analyzer and values for XKrox-20 and BF-1 transcripts with ( . ) or without (o) overexpression of XSRFDC, which are normalized to EF1a transcript, are presented as percentages of the respective maximum value and plotted against bFGF dose (lower graphs).
additional repressor or enhancer elements outside the cloned genomic sequence that regulate the correct spatial expression of XKrox-20. Alternatively, or in addition, the correct chromatin configuration of the injected reporter constructs may be required for responding to activating factors in XKrox-20-expressing cells or responding to repressing factors in nonexpressing cells. Among these possibilities, it is interesting to note that such repressor elements have been reported for Xbra that is specifically expressed in the mesoderm (Lerchner et al., 2000) . These elements present in the 5V flanking sequence restrict Xbra expression to the mesoderm, which is induced by members of the TGF-h and FGF families of signaling polypeptides. It is also reported that elements in the first intron of Xlim-1 mediate repression of basal promoter activity and that this repression is relieved by activin signaling (Rebbert and Dawid, 1997) .
Several signaling molecules have been implicated to regulate expression of XKrox-20 in Xenopus embryos. These include FGF (Cox and Hemmati-Brivanlou, 1995; Hongo et al., 1999; Kengaku and Okamoto, 1995; Lamb and Harland, 1995; Wiellette and Sive, 2003) , Wnt proteins (Bang et al., 1999; Kiecker and Niehrs, 2001; McGrew et al., 1997) , and retinoic acid (Blumberg et al., 1997; Durston et al., 1989; Kolm and Sive, 1997) . Among them, FGF is of particular interest because expression of XKrox-20 in ectoderm cells in culture is induced by cocultured Spemann's organizer cells, neural inducing cells in vivo, and this expression is inhibited by overexpression of a dominant-negative construct of Xenopus FGF receptor type-4 (Hongo et al., 1999) . More recently, the same dominantnegative construct has been reported to strongly reduce XKrox-20 expression in the hindbrain region (MonsoroBurq et al., 2003) . In addition, FGF signaling is involved in the normal regulation of Krox20 expression in the developing chick hindbrain, as indicated by both loss-and gainof-function experiments (Marin and Charnay, 2000a) . Further in this study, we showed that FGF induces Xenopus ectoderm cells in culture to express XKrox-20 and that this induction is suppressed by inhibiting the function of SRF on the minimal promoter element. These results raise the possibility that FGF signaling is involved in the regulation of XKrox-20 through interaction with the minimal promoter. Indeed, there is a possible linkage between FGF signaling and the activity of the minimal promoter element of XKrox-20. A major transduction pathway from FGF signaling to its nuclear targets is the Ras/mitogen-activated protein kinase (MAPK) pathway (La Bonne and Whitman, 1997; MacNicol et al., 1993; Whitman and Melton, 1992) , and CREB is targeted by this pathway through MAPK-activated protein kinase (Tan et al., 1996) . Thus, FGF could directly activate the minimal promoter of XKrox-20 through phosphorylation of CREB. Alternatively, FGF may indirectly activate the minimal promoter through phosphorylation of Ets family transcription factors, other typical nuclear targets of the FGF/Ras/MAPK transduction pathway (Wasylyk et al., 1998) . In complex with SRF, CREB, and CBP mentioned earlier, Ets proteins are required to be phosphorylated for the complex to potentiate the initiation of transcription (Nissen et al., 2001 ). Thus, the higher-order complex comprising the SRF/CREB ternary complex, CBP and Ets, when activated through FGF signaling, would counteract the suppression of the minimal promoter activity by the putative repressor elements. We are currently investigating this model.
